Skip to main content
Clinical Trials/CTRI/2022/02/040389
CTRI/2022/02/040389Not yet recruitingPhase 2

Comparative evaluation of hemodynamic response with FASTRACH intubating laryngeal airway and laryngoscopic intubation.

Dr DY Patil Vidyapeeth0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. ASA grade I or II fit patients. 2. Ages between 18 and 65 years female and male patients. 3. Patients undergoing any orthopaedic and abdominal surgeries, requiring tracheal intubation for general anesthesia .
  • 4. Heamodynamically stable patients with all routine investigations within normal limits
  • without any other co morbidities.
  • 5. Availability of informed consent.

Exclusion Criteria

  • 1. Patients with ASA physical status III or more.
  • 2. Patients with major neurological, cardiac, respiratory, metabolic, renal, hepatic disease or
  • with coagulation abnormalities.
  • 3. Patients with known allergies to the study drug.
  • 4. Patients who are not consenting to the above study.
  • 5. Patients below 18 years and above 65 years of age.
  • 6.Patients with difficult airway
  • 8. The patients with Mallampati grade III or IV

Investigators

Sponsor
Dr DY Patil Vidyapeeth

Similar Trials